mandol inj 1gm/amp powder for solution
eli lilly canada inc - cefamandole nafate - powder for solution - 1g - cefamandole nafate 1g - second generation cephalosporins
mandol add-vantage inj 1gm/vial powder for solution
eli lilly canada inc - cefamandole (cefamandole nafate) - powder for solution - 1g - cefamandole (cefamandole nafate) 1g - second generation cephalosporins
mandol cefamandole 500mg (as nafate) powder for injection
aspen pharmacare australia pty ltd - cefamandole, quantity: 500 mg - injection, powder for - excipient ingredients: sodium carbonate - cephamandole nafate is indicated for the treatment of the following infections when sue to susceptible organisms (see pharmacolocy: anti-bacterial activity). (1) respiratory tract infections. (2) genito-urinary tract infections. (3) peritonitis and other intra-abdominal and intra-pelvic infections. (4) septicaemia. (5) skin ans soft-tissue infections. (6) bone and joint infections. note: concentrations of cephamandole in the csf are considerably lower than in the plasma, its use in the treatment of bacterial meningitis and brain abscess is therefore not advised. indications as at 30 june 94: mandol is indicated for the treatment of serious infections of the respiratory tract, genitourinary tract, skin and soft tissue, bones and joints, septicaemia, gall bladder and peritoneum when due to susceptible strains of the above mentioned organisms. concentrations of mandol in the csf are considerably lower than in the plasma; use in the treatment of meningitis and brain abscess is therefore not advised. specimens for
kefadol 1g powder for solution for injection vials
dista products ltd - cefamandole nafate - powder for solution for injection - 1gram
kefadol pdr for soln for injection 500 milligram
eli lilly and company limited - cefamandole nafate - pdr for soln for injection - 500 milligram
kefadol pdr for soln for injection 1.0 grams
eli lilly and company limited - cefamandole nafate - pdr for soln for injection - 1.0 grams
kefadol pdr for soln for injection 2.0 grams
eli lilly and company limited - cefamandole nafate - pdr for soln for injection - 2.0 grams
mandol 1g powder for injection
aspen pharmacare australia pty ltd - cefamandole, quantity: 1 g - injection, powder for - excipient ingredients: sodium carbonate - cephamandole nafate is indicated for the treatment of the following infections when sue to susceptible organisms (see pharmacolocy: anti-bacterial activity). (1) respiratory tract infections. (2) genito-urinary tract infections. (3) peritonitis and other intra-abdominal and intra-pelvic infections. (4) septicaemia. (5) skin ans soft-tissue infections. (6) bone and joint infections. note: concentrations of cephamandole in the csf are considerably lower than in the plasma, its use in the treatment of bacterial meningitis and brain abscess is therefore not advised. indications as at 30 june 94: mandol is indicated for the treatment of serious infections of the respiratory tract, genitourinary tract, skin and soft tissue, bones and joints, septicaemia, gall bladder and peritoneum when due to susceptible strains of the above mentioned organisms. concentrations of mandol in the csf are considerably lower than in the plasma; use in the treatment of meningitis and brain abscess is therefore not advised. specimens for
kefadol 0.75
eli lilly and company limited - cefamandole nafate - 0.75
adco cefamandole 1 g solution
adcock ingram limited - solution - each vial contains cefamandole nafate equivalent to cefamandole 1,0 g